SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-17-005713
Filing Date
2017-03-31
Accepted
2017-03-31 11:55:38
Documents
92
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K dffn20161231_10k.htm 10-K 1723825
2 EXHIBIT 3.1 ex3-1.htm EX-3.1 35229
3 EXHIBIT 10.5 ex10-5.htm EX-10.5 77900
4 EXHIBIT 10.17 ex10-17.htm EX-10.17 32007
5 EXHIBIT 21.1 ex21-1.htm EX-21.1 11277
6 EXHIBIT 23.1 ex23-1.htm EX-23.1 3906
7 EXHIBIT 31.1 ex31-1.htm EX-31.1 15962
8 EXHIBIT 31.2 ex31-2.htm EX-31.2 15933
9 EXHIBIT 32.1 ex32-1.htm EX-32.1 10991
16 dffn20161231_10kimg011.jpg GRAPHIC 15270
17 chart.jpg GRAPHIC 59126
18 dffn20161231_10kimg009.gif GRAPHIC 21678
19 dffn20161231_10kimg008.jpg GRAPHIC 26866
20 dffn20161231_10kimg007.jpg GRAPHIC 19129
  Complete submission text file 0001437749-17-005713.txt   7324054

Data Files

Seq Description Document Type Size
10 EXHIBIT 101.INS dffn-20161231.xml EX-101.INS 1264799
11 EXHIBIT 101.SCH dffn-20161231.xsd EX-101.SCH 68981
12 EXHIBIT 101.CAL dffn-20161231_cal.xml EX-101.CAL 32760
13 EXHIBIT 101.DEF dffn-20161231_def.xml EX-101.DEF 528456
14 EXHIBIT 101.LAB dffn-20161231_lab.xml EX-101.LAB 392429
15 EXHIBIT 101.PRE dffn-20161231_pre.xml EX-101.PRE 542573
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37942 | Film No.: 17728941
SIC: 2834 Pharmaceutical Preparations